BioSpace News Archive

Solve FSHD exists to fund biotechnology and biopharmaceutical research and development efforts toward finding a treatment and cure for FSHD.

DNAnexus announced it has secured $200 million in funding to advance the life sciences industry’s adoption of its platform.

Shares of Adaptive are climbing this morning after the company announced a reorganization of priorities to spur future growth, including a workforce reduction of approximately 12%.

Recent technological advancements have pushed pharma employees to embrace new technologies and innovations in different areas.

This target date is the latest development in a long series of setbacks that Acadia - and other pharma companies - have experienced getting Alzheimer’s treatments approved.

Pfizer has launched a Phase II/III study to assess its oral antiviral Paxlovid in non-hospitalized symptomatic pediatric patients who are at risk for progression to serious disease.

Swedish Orphan Biovitrum AB and Sanofi announced positive top-line results from the pivotal XTEND-1 phase 3 study evaluating the safety, efficacy and pharmacokinetics of efanesoctocog alfa in previously treated patients ≥12 years of age with severe haemophilia A.

OSE Immunotherapeutics, announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα inhibitor BI 765063 in patients with advanced solid tumors have been selected for presentation in an in-person poster session at the American Association Cancer for Research annual meeting to be held on April 8 – 13, 2022 in New Orleans, Louisiana.

Midatech Pharma PLC, a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D collaboration with Janssen Pharmaceutica NV originally announced on 21 July 2020.

The industry analysis report is considered a valuable source of information about the global Nanoparticle Drug Delivery Systems industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.